Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool

Related Content

Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists

Feb 17 2003

CMS Critiques MADIT-II: “Inducible” Patients Should Have Been Excluded

Feb 10 2003

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window